All Stories

  1. Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers

    Article • Clinical and Translational Allergy, July 2026, Wiley

    Professor Marek Sanak

  2. Correction: Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction

    Article • Clinical Rheumatology, March 2026, Springer Science + Business Media

    Professor Marek Sanak

  3. Two Distinct Transcriptional Subtypes of Severe Type 2 Asthma in NSAID ‐Exacerbated Respiratory Disease

    Article • Clinical & Experimental Allergy, February 2026, Wiley

    Professor Marek Sanak

  4. Associations between TNF gene promoter variants (rs361525, rs1800629, rs1799964, rs1799724) and the clinical course of idiopathic inflammatory myopathies

    Article • Scientific Reports, November 2025, Springer Science + Business Media

    Professor Marek Sanak

  5. Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction

    Article • Clinical Rheumatology, November 2025, Springer Science + Business Media

    Professor Marek Sanak

  6. Circulating B Lymphocyte Subsets in Patients with Systemic Lupus Erythematosus

    Article • Medicina, December 2024, MDPI AG

    Professor Marek Sanak

  7. Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity

    Article • Clinical and Translational Allergy, December 2024, Wiley

    Professor Marek Sanak

  8. Role of Plasma Angiopoietin-1 and VEGF Levels as Potential Biomarkers in Chronic Central Serous Chorioretinopathy with Macular Neovascularization

    Article • International Journal of Molecular Sciences, October 2024, MDPI AG

    Professor Marek Sanak

  9. Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration

    Article • Medicina, May 2024, MDPI AG

    Professor Marek Sanak

  10. Circulating Anti-endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration

    Article • April 2024, MDPI AG

    Professor Marek Sanak

  11. Updates in AERD: What is needed further?

    Article • Journal of Allergy and Clinical Immunology, December 2023, Elsevier

    Professor Marek Sanak

  12. Comprehensive Analysis of Circular RNAs in Endothelial Cells

    Article • International Journal of Molecular Sciences, June 2023, MDPI AG

    Professor Marek Sanak

  13. Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study

    Article • Vaccines, April 2023, MDPI AG

    Professor Marek Sanak

  14. Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease

    Article • Clinical and Translational Allergy, March 2023, Wiley

    Professor Marek Sanak

  15. Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD

    Article • Allergy, September 2022, Wiley

    Professor Marek Sanak

  16. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis

    Article • iScience, June 2022, Elsevier

    Professor Marek Sanak

  17. Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis

    Article • Clinical & Experimental Immunology, March 2022, Oxford University Press (OUP)

    Professor Marek Sanak

  18. Intravenous administration of Tat-NR2B9c peptide, a PSD95 inhibitor, attenuates reinstatement of cocaine-seeking behavior in rats

    Article • Behavioural Brain Research, January 2022, Elsevier

    Professor Marek Sanak

  19. Dynamic in vitro hemocompatibility of oligoproline self-assembled monolayer surfaces

    Article • Biomaterials Science, January 2022, Royal Society of Chemistry

    Professor Marek Sanak

  20. MiR-191 as a Key Molecule in Aneurysmal Aortic Remodeling

    Article • Biomolecules, October 2021, MDPI AG

    Professor Marek Sanak

  21. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2021, Taylor & Francis

    Professor Marek Sanak

  22. The NMDA Receptor Subunit (GluN1 and GluN2A) Modulation Following Different Conditions of Cocaine Abstinence in Rat Brain Structures

    Article • Neurotoxicity Research, March 2021, Springer Science + Business Media

    Professor Marek Sanak

  23. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy

    Article • Journal of Clinical Medicine, March 2021, MDPI AG

    Professor Marek Sanak

  24. Endothelial cells response to neutrophil‐derived extracellular vesicles miRNAs in anti‐PR3 positive vasculitis

    Article • Clinical & Experimental Immunology, February 2021, Wiley

    Professor Marek Sanak

  25. miRNA Regulation of NK Cells Antiviral Response in Children With Severe and/or Recurrent Herpes Simplex Virus Infections

    Article • Frontiers in Immunology, January 2021, Frontiers

    Professor Marek Sanak

  26. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I

    Article • Allergy, January 2021, Wiley

    Professor Marek Sanak

  27. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study

    Article • American Review of Respiratory Disease, January 2021, American Thoracic Society

    Professor Marek Sanak

  28. Design, Manufacturing Technology and In-Vitro Evaluation of Original, Polyurethane, Petal Valves for Application in Pulsating Ventricular Assist Devices

    Article • Polymers, December 2020, MDPI AG

    Professor Marek Sanak

  29. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans

    Article • PLoS Pathogens, December 2020, PLOS

    Professor Marek Sanak

  30. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma

    Article • Allergy, December 2020, Wiley

    Professor Marek Sanak

  31. Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy

    Article • Pharmacological Reports, November 2020, Springer Science + Business Media

    Professor Marek Sanak

  32. Emerging role of non-coding RNAs in allergic disorders

    Article • Biomedicine & Pharmacotherapy, October 2020, Elsevier

    Professor Marek Sanak

  33. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs

    Article • AJP Lung Cellular and Molecular Physiology, September 2020, American Physiological Society

    Professor Marek Sanak

  34. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Professor Marek Sanak

  35. Association of Factor V Leiden With Subsequent Atherothrombotic Events

    Article • Circulation, August 2020, Wolters Kluwer Health

    Professor Marek Sanak

  36. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections

    Article • Biomedicine & Pharmacotherapy, August 2020, Elsevier

    Professor Marek Sanak

  37. Cocaine Self-Administration and Abstinence Modulate NMDA Receptor Subunits and Active Zone Proteins in the Rat Nucleus Accumbens

    Article • Molecules, July 2020, MDPI AG

    Professor Marek Sanak

  38. Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy

    Article • Acta Ophthalmologica, July 2020, Wiley

    Professor Marek Sanak

  39. A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2

    Article • Allergy, July 2020, Wiley

    Professor Marek Sanak

  40. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium

    Article • Journal of Virology, July 2020, ASM Journals

    Professor Marek Sanak

  41. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection

    Article • Vascular Pharmacology, July 2020, Elsevier

    Professor Marek Sanak

  42. Legends of Allergy/Immunology: Andrew Szczeklik

    Article • Allergy, March 2020, Wiley

    Professor Marek Sanak

  43. Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort

    Article • Allergy, March 2020, Wiley

    Professor Marek Sanak

  44. The interaction of laser radiation with tissue in the aspect of generating the process of decellularization in the preparation of animal origin autologous tissue

    Article • Acta of Bioengineering and Biomechanics, January 2020, Politechnika Wroclawska Oficyna Wydawnicza

    Professor Marek Sanak

  45. Subphenotypes of NSAID‐exacerbated respiratory disease identified by latent class analysis

    Article • Allergy, December 2019, Wiley

    Professor Marek Sanak

  46. Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration

    Article • Clinical and Translational Allergy, November 2019, Wiley

    Professor Marek Sanak

  47. LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis

    Article • Journal of Lipid Research, November 2019, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Marek Sanak

  48. IL-17–high asthma with features of a psoriasis immunophenotype

    Article • Journal of Allergy and Clinical Immunology, November 2019, Elsevier

    Professor Marek Sanak, Dr Massimo Caruso

  49. Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins

    Article • Scandinavian Journal of Rheumatology, October 2019, Taylor & Francis

    Professor Marek Sanak

  50. Cocaine-induced Changes in the Expression of NMDA Receptor Subunits

    Article • Current Neuropharmacology, October 2019, Bentham Science Publishers

    Professor Marek Sanak

  51. Subtypes of eosinophilic asthma with discrete gene pathway phenotypes

    Article • September 2019, European Respiratory Society (ERS)

    Professor Marek Sanak, Dr Massimo Caruso

  52. A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience

    Article • Hämostaseologie, July 2019, Thieme Publishing Group

    Professor Marek Sanak

  53. Stratification of asthma phenotypes by airway proteomic signatures

    Article • Journal of Allergy and Clinical Immunology, July 2019, Elsevier

    Professor Marek Sanak

  54. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease

    Article • Respiratory Medicine, June 2019, Elsevier

    Professor Marek Sanak

  55. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

    Article • European Respiratory Journal, April 2019, European Respiratory Society (ERS)

    Professor Marek Sanak, Dr Massimo Caruso

  56. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

    Article • Circulation Genomic and Precision Medicine, April 2019, Wolters Kluwer Health

    Professor Marek Sanak, Marie-Pierre Dubé

  57. Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma

    Article • Respiratory Medicine, April 2019, Elsevier

    Professor Marek Sanak

  58. Subsequent Event Risk in Individuals With Established Coronary Heart Disease

    Article • Circulation Genomic and Precision Medicine, April 2019, Wolters Kluwer Health

    Professor Marek Sanak, Marie-Pierre Dubé

  59. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti‐inflammatory drug‐induced urticaria

    Article • Allergy, February 2019, Wiley

    Professor Marek Sanak

  60. Stabilization of Synthetic Materials with Silver Particles

    Article • January 2019, Springer Science + Business Media

    Professor Marek Sanak

  61. Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin

    Article • Allergy, December 2018, Wiley

    Professor Marek Sanak

  62. Molecular profiling of regulatory T cells in pulmonary sarcoidosis

    Article • Journal of Autoimmunity, November 2018, Elsevier

    Professor Marek Sanak

  63. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease

    Article • October 2018, Springer Science + Business Media

    Professor Marek Sanak

  64. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper

    Article • Allergy, October 2018, Wiley

    Professor Marek L Kowalski, Professor Marek Sanak

  65. Facilitated expansion of Th17 cells in lupus nephritis patients

    Article • Clinical & Experimental Immunology, September 2018, Wiley

    Professor Marek Sanak, Professor JACEK MUSIAL

  66. Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort

    Article • PLOS One, September 2018, PLOS

    Dr Massimo Caruso, Professor Marek Sanak

  67. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers

    Article • Metabolomics, September 2018, Springer Science + Business Media

    Professor Marek Sanak

  68. U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes

    Article • September 2018, European Respiratory Society (ERS)

    Professor Marek Sanak, Dr Massimo Caruso

  69. Eicosanoids and eosinophilic inflammation of airways in stable COPD.

    Article • September 2018, European Respiratory Society (ERS)

    Professor Marek Sanak

  70. Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA

    Article • September 2018, European Respiratory Society (ERS)

    Professor Marek Sanak, Dr Massimo Caruso

  71. Correction to: Fibroblast-to-myofibroblast transition in bronchial asthma

    Article • Cellular and Molecular Life Sciences, August 2018, Springer Science + Business Media

    Professor Marek Sanak

  72. Surface modification of metallic materials designed for a new generation of artificial heart valves

    Article • The International Journal of Artificial Organs, August 2018, SAGE Publications

    Professor Roman Major, Professor Marek Sanak

  73. Fibroblast-to-myofibroblast transition in bronchial asthma

    Article • Cellular and Molecular Life Sciences, August 2018, Springer Science + Business Media

    Professor Marek Sanak

  74. Aspirin resistance

    Article • MOJ Bioorganic & Organic Chemistry, May 2018, MedCrave Group LLC

    Professor Marek Sanak

  75. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome

    Article • Journal of Proteome Research, May 2018, American Chemical Society (ACS)

    Dr Massimo Caruso, Professor Marek Sanak

  76. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis

    Article • Lupus, April 2018, SAGE Publications

    Professor Marek Sanak

  77. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma

    Article • The Journal of Allergy and Clinical Immunology In Practice, March 2018, Elsevier

    Professor Marek Sanak

  78. Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting

    Article • Journal of Cardiothoracic and Vascular Anesthesia, February 2018, Elsevier

    Professor Marek Sanak

  79. Influence of TNF-α promoter variability on stage and grade in individuals with colorectal cancer

    Article • Polish Journal of Pathology, January 2018, Termedia Sp. z.o.o.

    Professor Marek Sanak

  80. miR-200b downregulates CFTR during hypoxia in human lung epithelial cells

    Article • Cellular & Molecular Biology Letters, November 2017, Springer Science + Business Media

    Dr Jarosław Króliczewski, Professor Marek Sanak

  81. Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study

    Article • Polish Archives of Internal Medicine, November 2017, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  82. Biomimetics in thin film design: Niche-like wrinkles designed for i-cell progenitor cell differentiation

    Article • Materials Science and Engineering C, November 2017, Elsevier

    Professor Marek Sanak

  83. Respiratory syncytial virus infection influences tight junction integrity

    Article • Clinical & Experimental Immunology, October 2017, Wiley

    Professor Marek Sanak

  84. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients

    Article • Clinical & Experimental Allergy, September 2017, Wiley

    Professor Marek Sanak

  85. Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects

    Article • Cytokine, September 2017, Elsevier

    Professor Marek Sanak

  86. Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort

    Article • September 2017, European Respiratory Society (ERS)

    Dr Massimo Caruso, Professor Marek Sanak

  87. Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort

    Article • September 2017, European Respiratory Society (ERS)

    Professor Marek Sanak, Dr Massimo Caruso

  88. Connexin43 Controls the Myofibroblastic Differentiation of Bronchial Fibroblasts from Patients with Asthma

    Article • American Journal of Respiratory Cell and Molecular Biology, July 2017, American Thoracic Society

    Professor Marek Sanak

  89. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

    Article • The Lancet Diabetes & Endocrinology, July 2017, Elsevier

    Professor Marek Sanak

  90. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331

    Article • British Journal of Cancer, June 2017, Springer Science + Business Media

    Professor Marek Sanak

  91. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

    Article • Journal of Allergy and Clinical Immunology, June 2017, Elsevier

    Dr Massimo Caruso, Professor Marek Sanak

  92. Cocaine Administration and Its Withdrawal Enhance the Expression of Genes Encoding Histone-Modifying Enzymes and Histone Acetylation in the Rat Prefrontal Cortex

    Article • Neurotoxicity Research, April 2017, Springer Science + Business Media

    Professor Marek Sanak

  93. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis

    Article • European Journal of Immunology, February 2017, Wiley

    Professor JACEK MUSIAL, Professor Marek Sanak

  94. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

    Article • The Lancet Respiratory Medicine, January 2017, Elsevier

    Conjoint Professor Peter Wark, Professor Marek Sanak

  95. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients

    Article • Journal of Allergy and Clinical Immunology, January 2017, Elsevier

    Professor Marek Sanak

  96. Urinary prostanoids in preschool wheeze

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Professor David Price, Prof. John W Holloway, Professor Marek Sanak

  97. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies

    Article • Pharmacological Reports, December 2016, Elsevier

    Professor Marek Sanak

  98. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, November 2016, Elsevier

    Professor Marek Sanak

  99. Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology

    Article • The Annals of Thoracic Surgery, October 2016, Elsevier

    Professor Marek Sanak

  100. The genetic evidence for human origin of Jivaroan shrunken heads in collections from the Polish museums

    Article • International Journal of Legal Medicine, September 2016, Springer Science + Business Media

    Professor Marek Sanak

  101. Effect of DHA/EPA supplementation on endothelial damage markers. The bioclaims study

    Article • Atherosclerosis, September 2016, Elsevier

    Professor Marek Sanak

  102. Urinary 11‐Dehydro‐Thromboxane B 2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

    Article • Journal of the American Heart Association, August 2016, Wolters Kluwer Health

    Professor Marek Sanak

  103. Pentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition

    Article • Acta Biochimica Polonica, July 2016, Polskie Towarzystwo Biochemiczne (Polish Biochemical Society)

    Professor Marek Sanak

  104. Wrinkle-like structures in reconstructing stem cell niches

    Article • New Biotechnology, July 2016, Elsevier

    Professor Marek Sanak

  105. Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab

    Article • Acta Ophthalmologica, June 2016, Wiley

    Professor Marek Sanak

  106. Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease

    Article • Atherosclerosis, June 2016, Elsevier

    Professor Marek Sanak

  107. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease

    Article • Annals of Allergy Asthma & Immunology, April 2016, Elsevier

    Professor Marek Sanak

  108. Nanostructural haemocompatible coatings for the internal side of artificial blood vessels

    Article • IOP Conference Series Materials Science and Engineering, March 2016, Institute of Physics Publishing

    Professor Marek Sanak

  109. Silver nanoparticles influence on the blood activation process and their release to blood plasma from synthetic polymer scaffold

    Article • IOP Conference Series Materials Science and Engineering, March 2016, Institute of Physics Publishing

    Professor Marek Sanak

  110. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland

    Article • Metabolism, March 2016, Elsevier

    Professor Marek Sanak

  111. Lesions in the wingless gene of the Apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings, coming from the isolated population in Pieniny (Poland)

    Article • Gene, February 2016, Elsevier

    Professor Marek Sanak

  112. Prostaglandin E2in Induced Sputum Following Oralaspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity

    Article • Journal of Allergy and Clinical Immunology, February 2016, Elsevier

    Professor Marek Sanak

  113. Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?

    Article • Allergy Asthma and Immunology Research, January 2016, The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

    Professor Marek Sanak

  114. Physicochemical and Biological Investigation of Different Structures of Carbon Coatings Deposited onto Polyurethane

    Article • Brazilian Archives of Biology and Technology, January 2016, FapUNIFESP (SciELO)

    Professor Marek Sanak

  115. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease

    Article • Cytokine, January 2016, Elsevier

    Professor Marek Sanak

  116. Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma

    Article • Clinical & Experimental Allergy, November 2015, Wiley

    Professor Marek Sanak

  117. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier

    Article • Journal of Allergy and Clinical Immunology, November 2015, Elsevier

    Professor Marek Sanak

  118. A lack of Wolbachia-specific DNA in samples from apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings

    Article • Journal of Applied Genetics, September 2015, Springer Science + Business Media

    Professor Marek Sanak

  119. Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways

    Article • September 2015, European Respiratory Society (ERS)

    Professor Marek Sanak

  120. The first U-BIOPRED sputum handprint of severe asthma

    Article • September 2015, European Respiratory Society (ERS)

    Professor Marek Sanak

  121. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics

    Article • Prostaglandins & Other Lipid Mediators, September 2015, Elsevier

    Professor Marek Sanak

  122. Mortality in end‑stage renal disease: the importance of the genetic background

    Article • Polish Archives of Internal Medicine, August 2015, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  123. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema

    Article • Journal of Allergy and Clinical Immunology, August 2015, Elsevier

    Professor Marek Sanak

  124. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia

    Article • Angiology, July 2015, SAGE Publications

    Professor Marek Sanak

  125. Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis

    Article • Current Genomics, July 2015, Bentham Science Publishers

    Professor Marek Sanak

  126. T-cell regulation during viral and nonviral asthma exacerbations

    Article • Journal of Allergy and Clinical Immunology, July 2015, Elsevier

    Professor Marek Sanak

  127. Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis

    Article • Clinical & Experimental Immunology, May 2015, Wiley

    Professor Marek Sanak

  128. In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration

    Article • Acta Ophthalmologica, May 2015, Wiley

    Professor Marek Sanak

  129. Computer engineering in designing and fabrication of tissue analogue-type coating dedicated for the cardiovascular regeneration

    Article • Archives of Civil and Mechanical Engineering, May 2015, Springer Science + Business Media

    Professor Marek Sanak

  130. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells

    Article • PLOS One, April 2015, PLOS

    Professor Marek Sanak

  131. Erratum to: A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland

    Article • Molecular Biology Reports, April 2015, Springer Science + Business Media

    Professor Marek Sanak

  132. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency

    Article • Pharmacological Reports, April 2015, Springer Science + Business Media

    Professor Marek Sanak

  133. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients

    Article • Archivum Immunologiae et Therapiae Experimentalis, March 2015, Springer Science + Business Media

    Professor Marek Sanak

  134. Unravelling adverse reactions to NSAIDs using systems biology

    Article • Trends in Pharmacological Sciences, March 2015, Elsevier

    Professor Marek Sanak

  135. Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts

    Article • PLOS One, February 2015, PLOS

    Professor Marek Sanak

  136. Lack of association ofALOX12andALOX15Bpolymorphisms with psoriasis despite altered urinary excretion of 12(S)-hydroxyeicosatetraenoic acid

    Article • British Journal of Dermatology, November 2014, Wiley

    Professor Marek Sanak

  137. S65 Urinary Prostaglandins As Inflammatory Markers For Childhood Asthma Exacerbations

    Article • Thorax, November 2014, BMJ

    Professor Marek Sanak

  138. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial

    Article • The Lancet Respiratory Medicine, October 2014, Elsevier

    Prof. John W Holloway, Professor Marek Sanak

  139. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study

    Article • Journal of Allergy and Clinical Immunology, October 2014, Elsevier

    Professor Marek Sanak

  140. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity

    Article • Allergy, September 2014, Wiley

    Professor Marek Sanak

  141. Graphene based porous coatings with antibacterial and antithrombogenous function—Materials and design

    Article • Archives of Civil and Mechanical Engineering, August 2014, Elsevier

    Professor Marek Sanak

  142. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland

    Article • Scandinavian Journal of Infectious Diseases, July 2014, Taylor & Francis

    Professor Marek Sanak

  143. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children

    Article • Annals of Agricultural and Environmental Medicine, June 2014, Institute of Rural Health

    Professor Marek Sanak

  144. AB0029 Imbalance between Immunoregulatory and Effector TH17 Pathway in Active Sle

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Professor Marek Sanak

  145. THU0498 Increase of CXCR3-CCR4+CCR6+CCR10- Memory T Helper Cells (TH17-LIKE) in Patients with Granulomatosis and Polyangiitis (GPA)

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Professor Marek Sanak

  146. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration

    Article • Acta Ophthalmologica, May 2014, Wiley

    Professor Marek Sanak

  147. Th2-type cytokine induced mucous metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection

    Article • American Journal of Respiratory Cell and Molecular Biology, March 2014, American Thoracic Society

    Professor Marek Sanak

  148. Carbon in airway macrophages from children with asthma

    Article • Thorax, February 2014, BMJ

    Professor Marek Sanak

  149. Risk factors for arterial thrombosis in antiphospholipid syndrome

    Article • Thrombosis Research, February 2014, Elsevier

    Professor JACEK MUSIAL, Professor Marek Sanak

  150. Phagocytosis of fossil fuel particulates by macrophages in children with asthma

    Article • The Lancet, February 2014, Elsevier

    Professor Marek Sanak

  151. Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells

    Article • Prostaglandins & Other Lipid Mediators, October 2013, Elsevier

    Professor Marek Sanak

  152. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs

    Article • Allergy, July 2013, Wiley

    Professor Marek Sanak

  153. Grubość kompleksu błona wewnętrzna – błona środkowa tętnicy szyjnej koreluje z cechami zespołu metabolicznego u osób młodych z kliniczną diagnozą rodzinnej hipercholesterolemii

    Article • Kardiologia Polska, June 2013, VM Media SP. zo.o VM Group SK

    Professor Marek Sanak

  154. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener’s) patients

    Article • Clinical Rheumatology, June 2013, Springer Science + Business Media

    Professor Marek Sanak

  155. Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs

    Article • Immunology and Allergy Clinics of North America, May 2013, Elsevier

    Professor Marek Sanak

  156. Mutations of microsatellite autosomal loci in paternity investigations of the Southern Poland population

    Article • Forensic Science International Genetics, May 2013, Elsevier

    Professor Marek Sanak

  157. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs

    Article • Clinical & Experimental Allergy, April 2013, Wiley

    Professor Marek Sanak

  158. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients

    Article • La Presse Médicale, April 2013, Elsevier

    Professor Marek Sanak

  159. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations

    Article • Pharmacological Reports, January 2013, Springer Science + Business Media

    Professor Marek Sanak

  160. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4

    Article • Polish Archives of Internal Medicine, July 2012, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  161. Transforming growth factor-β1‑induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients

    Article • Polish Archives of Internal Medicine, July 2012, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  162. Exhaled eicosanoid profiles in children with atopic asthma and healthy controls

    Article • Pediatric Pulmonology, July 2012, Wiley

    Professor Marek Sanak

  163. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients

    Article • Rheumatology, July 2012, Oxford University Press (OUP)

    Professor Marek Sanak

  164. Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much more: Figure 1–

    Article • European Respiratory Journal, May 2012, European Respiratory Society (ERS)

    Professor Marek Sanak

  165. Biographical memoir: Andrew Szczeklik 29 June 1938–3 February 2012

    Article • Vascular Pharmacology, May 2012, Elsevier

    Professor Marek Sanak

  166. CCR4-active chemokines contribute to blood and tissue eosinophilia in Churg–Strauss syndrome

    Article • Vascular Pharmacology, May 2012, Elsevier

    Professor Marek Sanak

  167. Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers

    Article • Journal of Functional Biomaterials, April 2012, MDPI AG

    Professor Marek Sanak

  168. The unfinished history of aspirin hypersensitivity – in memory of Professor Andrew Szczeklik

    Article • Polish Archives of Internal Medicine, April 2012, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  169. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome

    Article • Clinical & Experimental Allergy, March 2012, Wiley

    Professor Marek Sanak

  170. Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens

    Article • PLOS One, March 2012, PLOS

    Dr Katarzyna Gawron, Professor Marek Sanak

  171. Nasal Inflammatory Mediators In Non-steroidal Anti-inflammatory Drugs (nsaids) Cross-intolerant Subjects After Lysine Nasal Challenge

    Article • Journal of Allergy and Clinical Immunology, February 2012, Elsevier

    Professor Marek Sanak

  172. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus

    Article • Folia Histochemica et Cytobiologica, January 2012, VM Media SP. zo.o VM Group SK

    Professor Marek Sanak

  173. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C

    Article • World Journal of Gastroenterology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Marek Sanak

  174. The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b

    Article • Gastroenterology Review, January 2012, Termedia Sp. z.o.o.

    Professor Marek Sanak

  175. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland

    Article • Molecular Biology Reports, December 2011, Springer Science + Business Media

    Professor Marek Sanak

  176. Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell–cell contacts

    Article • Respiratory Medicine, October 2011, Elsevier

    Professor Marek Sanak

  177. Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration

    Article • Acta Ophthalmologica, August 2011, Wiley

    Professor Marek Sanak

  178. 832 INTIMA-MEDIA THICKNESS CORRELATES WITH FEATURES OF METABOLIC SYNDROME IN YOUNG PERSONS WITH CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Marek Sanak

  179. 592 MUTATION SPECTRUM IN THE LDL RECEPTOR GENE IN PATIENTS FROM THE SOUTH-EASTERN PART OF POLAND

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Marek Sanak

  180. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype

    Article • Journal of Allergy and Clinical Immunology, May 2011, Elsevier

    Professor Marek Sanak

  181. Functional cardio-biomaterials

    Article • Advances in Materials Science, January 2011, De Gruyter

    Professor Marek Sanak

  182. Coxibs strike back

    Article • Clinical & Experimental Allergy, December 2010, Wiley

    Professor Marek Sanak

  183. Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation

    Article • International Journal of Cardiology, December 2010, Elsevier

    Professor Marek Sanak

  184. Eoxins: A new inflammatory pathway in childhood asthma

    Article • Journal of Allergy and Clinical Immunology, October 2010, Elsevier

    Professor Marek Sanak

  185. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery

    Article • Polish Archives of Internal Medicine, September 2010, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  186. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects

    Article • Journal of Chromatography B, July 2010, Elsevier

    Professor Marek Sanak

  187. Glucocorticoid receptor isoforms in steroid‑dependent asthma

    Article • Polish Archives of Internal Medicine, June 2010, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  188. MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATION

    Article • Atherosclerosis Supplements, June 2010, Elsevier

    Professor Marek Sanak

  189. Elevated urinary leukotriene E4excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA

    Article • Allergy, May 2010, Wiley

    Professor Marek Sanak

  190. Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease

    Article • Polish Archives of Internal Medicine, March 2010, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  191. Assessment of hemocompatibility of materials with arterial blood flow by platelet functional tests

    Article • Bulletin of the Polish Academy of Sciences Technical Sciences, January 2010, De Gruyter

    Professor Marek Sanak

  192. Interaction of functionalFCER2promoter polymorphism and phenotype-associated haplotypes

    Article • Tissue Antigens, December 2009, Wiley

    Professor Marek Sanak

  193. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome

    Article • Rheumatology, July 2009, Oxford University Press (OUP)

    Professor Marek Sanak

  194. Genetic associations of variants of the high affinity receptor for immunoglobulin E in Wegener’s granulomatosis

    Article • Polish Archives of Internal Medicine, March 2009, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Professor Marek Sanak

  195. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years

    Article • Journal of Allergy and Clinical Immunology, January 2009, Elsevier

    Professor Marek Sanak

  196. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease

    Article • Thrombosis and Haemostasis, October 2008, Schattauer GmbH

    Professor Marek Sanak

  197. Single-stranded conformation polymorphism (SSCP)-driven indirect sequencing in detection of short deletion

    Article • Molecular Biology Reports, September 2008, Springer Science + Business Media

    Professor Marek Sanak

  198. Genetic variability of the high-affinity IgE receptor α-subunit (FcεRIα)

    Article • Immunologic Research, August 2008, Springer Science + Business Media

    Professor Marek Sanak

  199. FCER1Agene proximal promoter polymorphisms in Caucasians and East Asians

    Article • International Journal of Immunogenetics, August 2008, Wiley

    Professor Marek Sanak

  200. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma

    Article • Pediatric Allergy and Immunology, July 2008, Wiley

    Professor Marek Sanak, Prof.Dr. Alexander Moeller

  201. Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome

    Article • Allergy, June 2008, Wiley

    Professor Marek Sanak

  202. Two Different Transcription Factors Discriminate the −315C>T Polymorphism of the FcεRIα Gene: Binding of Sp1 to −315C and of a High Mobility Group-Related Molecule to −315T

    Article • The Journal of Immunology, June 2008, The American Association of Immunologists

    Professor Marek Sanak

  203. The Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma

    Article • American Review of Respiratory Disease, May 2008, American Thoracic Society

    Professor Marek Sanak

  204. FCER1A gene exon 1A polymorphisms in Japanese and Polish subjects – a comparative analysis of haplotypes

    Article • Allergy, May 2008, Wiley

    Professor Marek Sanak

  205. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity

    Article • Thorax, January 2008, BMJ

    Professor Marek Sanak

  206. The prevalence of alpha1-antitrypsin deficiency in a representative population sample from Poland

    Article • Respiratory Medicine, December 2007, Elsevier

    Professor Marek Sanak

  207. Molecular diagnostics of α1-antitrypsin deficiency

    Article • Expert Opinion on Medical Diagnostics, October 2007, Informa Healthcare

    Professor Marek Sanak

  208. Coding region for the high affinity receptor of immunoglobulin E is highly conservative in allergic patients

    Article • Clinical & Experimental Allergy, September 2007, Wiley

    Professor Marek Sanak

  209. Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels

    Article • Allergy, September 2007, Wiley

    Professor Marek Sanak

  210. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin

    Article • Thrombosis and Haemostasis, June 2007, Schattauer GmbH

    Professor Marek Sanak

  211. FCERIA gene promoter polymorphisms: Lack of association with aspirin hypersensitivity in whites

    Article • Journal of Allergy and Clinical Immunology, May 2007, Elsevier

    Professor Marek Sanak

  212. GENETIC POLYMORPHISMS OF THE NOVEL FCER1A GENE REGION: RELATION TO TOTAL SERUM IgE LEVELS

    Article • Annals of Allergy Asthma & Immunology, May 2007, Elsevier

    Professor Marek Sanak

  213. Rapid and Inexpensive Detection of α1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening

    Article • Journal of Molecular Diagnostics, February 2007, Elsevier

    Professor Marek Sanak

  214. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease

    Article • Thrombosis Research, January 2007, Elsevier

    Professor Marek Sanak

  215. Genetic Variability of the High-affinity IgE Receptor α Subunit (Fc ε RI α) is Related to Total Serum IgE levels in Allergic Subjects

    Article • Allergology International, January 2007, Japanese Society of Allergology

    Professor Marek Sanak

  216. Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management

    Article • January 2007, Karger Publishers

    Professor Marek Sanak

  217. NOVEL EXON 2A OF THE HIGH-AFFINITY RECEPTOR FOR THE IgE α-CHAIN GENE (FCER1A) AND AUTOIMMUNITY IN PATIENTS WITH ASTHMA OR URTICARIA

    Article • Annals of Allergy Asthma & Immunology, November 2006, Elsevier

    Professor Marek Sanak

  218. Towards a Multidisciplinary and Integrated Strategy in the Assessment of Adverse Health Effects Related to Air Pollution: The Case Study of Cracow (Poland) and Asthma

    Article • Epidemiology, November 2006, Wolters Kluwer Health

    Professor Marek Sanak

  219. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria

    Article • Journal of Allergy and Clinical Immunology, October 2006, Elsevier

    Professor Marek Sanak

  220. The α-chain of high-affinity receptor for IgE (FcɛRIα) gene polymorphisms and serum IgE levels

    Article • Allergy, October 2006, Wiley

    Professor Marek Sanak

  221. Towards a multidisciplinary and integrated strategy in the assessment of adverse health effects related to air pollution: The case study of Cracow (Poland) and asthma

    Article • Environmental Pollution, September 2006, Elsevier

    Professor Marek Sanak

  222. Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies

    Article • Lupus, April 2006, SAGE Publications

    Professor Marek Sanak

  223. The broken balance in aspirin hypersensitivity

    Article • European Journal of Pharmacology, March 2006, Elsevier

    Professor Marek Sanak

  224. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant

    Article • British Journal of Dermatology, February 2006, Wiley

    Professor Marek Sanak

  225. Rhinovirus Infection in Lower Airways of Asthmatic Patients

    Article • Journal of Allergy and Clinical Immunology, February 2006, Elsevier

    Professor Marek Sanak

  226. Reactive Oxygen Species Metabolism and Allergy

    Article • Allergy & Clinical Immunology International - Journal of the World Allergy Organization, January 2006, Hogrefe Publishing Group

    Professor Marek Sanak

  227. Anti-thrombotic action of clopidogrel and PlA1/A2polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin

    Article • Thrombosis and Haemostasis, November 2005, Schattauer GmbH

    Professor Marek Sanak

  228. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism

    Article • Journal of Thoracic and Cardiovascular Surgery, September 2005, Elsevier

    Professor Marek Sanak

  229. Aspirin resistance

    Article • Journal of Thrombosis and Haemostasis, August 2005, Wiley

    Professor Marek Sanak

  230. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma

    Article • Journal of Allergy and Clinical Immunology, July 2005, Elsevier

    Professor Marek Sanak

  231. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib

    Article • European Journal Of Haematology, July 2005, Wiley

    Professor Marek Sanak

  232. The dopamine D4 receptor VNTR in Polish schizophrenia patients

    Article • Schizophrenia Research, February 2005, Elsevier

    Professor Marek Sanak

  233. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients

    Article • Clinical & Experimental Allergy, December 2004, Wiley

    Professor Marek Sanak

  234. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma

    Article • Journal of Allergy and Clinical Immunology, August 2004, Elsevier

    Professor Marek Sanak

  235. Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications

    Article • Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, June 2004, Bentham Science Publishers

    Professor Marek Sanak

  236. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression

    Article • European Journal of Pharmacology, May 2004, Elsevier

    Professor Marek Sanak

  237. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma

    Article • Journal of Allergy and Clinical Immunology, April 2004, Elsevier

    Professor Marek Sanak

  238. Aspirin intolerance and the cyclooxygenase???leukotriene pathways

    Article • Current Opinion in Pulmonary Medicine, January 2004, Wolters Kluwer Health

    Professor Marek Sanak

  239. X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A "European Community Alport Syndrome Concerted Action" Study

    Article • Journal of the American Society of Nephrology, October 2003, American Society of Nephrology

    Professor Marek Sanak

  240. Aspirin and thrombinogenesis

    Article • Thrombosis Research, June 2003, Elsevier

    Professor Marek Sanak

  241. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma

    Article • Journal of Allergy and Clinical Immunology, May 2003, Elsevier

    Professor Marek Sanak

  242. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis

    Article • European Respiratory Journal, January 2003, European Respiratory Society (ERS)

    Professor Marek Sanak

  243. 3P-0859 The accuracy of D-dimer testing in patients with venous thromboembolism disease

    Article • Atherosclerosis Supplements, January 2003, Elsevier

    Professor Marek Sanak

  244. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist

    Article • European Journal of Clinical Investigation, December 2002, Wiley

    Professor Marek Sanak

  245. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease

    Article • Blood Coagulation & Fibrinolysis, July 2002, Wolters Kluwer Health

    Professor Marek Sanak

  246. Repeated imipramine and electroconvulsive shock increase α1A-adrenoceptor mRNA level in rat prefrontal cortex

    Article • European Journal of Pharmacology, May 2002, Elsevier

    Professor Marek Sanak

  247. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors

    Article • Clinical & Experimental Allergy, March 2002, Wiley

    Professor Marek Sanak

  248. Montelukast for persistent asthma

    Article • The Lancet, October 2001, Elsevier

    Professor Marek Sanak

  249. Serum interleukin-5 in aspirin-induced asthma

    Article • Clinical & Experimental Allergy, July 2001, Wiley

    Professor Marek Sanak

  250. Leukotriene C4 synthase polymorphism and aspirin-induced asthma

    Article • Journal of Allergy and Clinical Immunology, March 2001, Elsevier

    Professor Marek Sanak

  251. Aspirin-induced rhinitis and asthma

    Article • Current Opinion in Allergy and Clinical Immunology, February 2001, Wolters Kluwer Health

    Professor Marek Sanak

  252. Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia

    Article • American Journal of Medical Genetics, January 2001, Wiley

    Professor Marek Sanak

  253. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma

    Article • Clinical & Experimental Allergy, December 2000, Wiley

    Professor Marek Sanak

  254. Genetics of aspirin induced asthma

    Article • Thorax, October 2000, BMJ

    Professor Marek Sanak

  255. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa

    Article • British Journal of Haematology, September 2000, Wiley

    Professor Marek Sanak

  256. Enhanced Expression of the Leukotriene C4Synthase Due to Overactive Transcription of an Allelic Variant Associated with Aspirin-Intolerant Asthma

    Article • American Journal of Respiratory Cell and Molecular Biology, September 2000, American Thoracic Society

    Professor Marek Sanak

  257. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics

    Article • European Respiratory Journal, July 2000, European Respiratory Society (ERS)

    Professor Marek Sanak

  258. X-linked Alport Syndrome

    Article • Journal of the American Society of Nephrology, April 2000, American Society of Nephrology

    Professor Marek Sanak

  259. Frequency data on the loci vWA, FES/FPS, F13A01, TH01, TPOX and CSF1P0 in a population from South Poland

    Article • International Journal of Legal Medicine, February 2000, Springer Science + Business Media

    Professor Marek Sanak

  260. Genetic Mechanisms in Aspirin-induced Asthma

    Article • American Review of Respiratory Disease, February 2000, American Thoracic Society

    Professor Marek Sanak

  261. Molecular Studies in Osteogenesis Imperfecta (OI)

    Article • Pediatric Research, June 1999, Springer Science + Business Media

    Professor Marek Sanak

  262. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma

    Article • Clinical & Experimental Allergy, March 1999, Wiley

    Professor Marek Sanak

  263. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation

    Article • The Lancet, March 1999, Elsevier

    Professor Marek Sanak

  264. Data on the loci LDLR, GYPA, HBGG, D7S8 and GC in a South Polish population

    Article • International Journal of Legal Medicine, February 1998, Springer Science + Business Media

    Professor Marek Sanak

  265. Role of leukotrienes in aspirin-induced asthma

    Article • January 1998, Springer Science + Business Media

    Professor Marek Sanak

  266. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma

    Article • The Lancet, November 1997, Elsevier

    Professor Marek Sanak

  267. D1S80 VNTR locus genotypes in population of South Poland; meta-analysis pointer to genetic disequilibrium of human populations

    Article • Forensic Science International, October 1995, Elsevier

    Professor Marek Sanak

  268. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1

    Article • Nature Genetics, May 1995, Springer Science + Business Media

    Professor Marek Sanak

  269. Fine deletion mapping of the p22 region of the human X chromosome using a radiation-induced hybrid panel

    Article • Cytogenetic and Genome Research, January 1995, Karger Publishers

    Professor Marek Sanak

  270. A gene for achondroplasia–hypochondroplasia maps to chromosome 4p

    Article • Nature Genetics, March 1994, Nature

    Professor Marek Sanak

  271. Limnology Of Missouri Reservoirs: An Analysis of Regional Patterns

    Article • Lake and Reservoir Management, May 1993, Taylor & Francis

    Professor Marek Sanak

  272. Alport syndrome: a genetic study of 31 families

    Article • Human Genetics, December 1992, Springer Science + Business Media

    Professor Marek Sanak

  273. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 collagen gene

    Article • Kidney International, November 1992, Elsevier

    Professor Marek Sanak

  274. 165 MOLECULAR ANALYSIS OF PKU HAPLOTYPES IN THE POPULATION OF SOUTHERN POLAND

    Article • Pediatric Research, September 1990, Springer Science + Business Media

    Professor Marek Sanak

  275. 166 TIME-PLACE CLUSTERS ANALYSIS FOR SELECTED CONGENITAL MALFORMATION IN SOUTHERN POLAND

    Article • Pediatric Research, September 1990, Springer Science + Business Media

    Professor Marek Sanak

  276. Hypersensitivity to Aspirin and other NSAIDs

    Article • Wiley

    Professor Marek Sanak